Brazil: Spending On Meds Acquired Through Law Suits Rockets
Executive Summary
Brazilian health ministry spending on medicines and treatment supplies acquired by patients taking legal action through the courts has rocketed from R$70m ($22.3) in 2008 to more than R$1bn ($317.9) in 2015, according to an audit by Brazil’s General Accounting Office (TCU).
You may also be interested in...
Brazil Needs Better Orphan Drug Policies, Says Alexion
Strengthening Brazil’s policy on orphan drugs would help stem the number of court cases brought by patients to access medicines, says Alexion.
Lack Of Industry Involvement In EU HTA Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
German HTA Queries Polivy Benefits Amid Lack Of Evidence
Roche’s lymphoma drug Polivy could face pricing challenges in Germany as it undergoes a full benefit assessment.